Sky Century Investment (SKYI) Interest Expenses (2024 - 2025)

Sky Century Investment (SKYI) reported Interest Expenses of $81.0 for Q1 2025, down 84.21% quarter-over-quarter from $513.0 in Q4 2024.

Sky Century Investment (SKYI) Interest Expenses (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Interest Expenses data on file, last reported at $81.0 in Q1 2025.

Interest Expenses for Q1 2025 came in at $81.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was $81.0 (down 84.21% YoY), and the FY2025 annual result was $594.0, changed N/A from the prior year.
Interest Expenses eased to $81.0 in Q1 2025 per SKYI's latest filing, from $513.0 in the prior quarter.
Over five years, Interest Expenses peaked at $513.0 in Q4 2024 and troughed at $81.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	62.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	3.00 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	57.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	20.89 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	4.86 Mn
10	Sky Century Investment	-	-	31,666.00	-

Download Data